Alphatec Holdings logo
Alphatec Holdings ATEC
$ 10.97 0.0%

Annual report 2025
added 02-24-2026

report update icon

Alphatec Holdings Financial Statements 2011-2026 | ATEC

Annual Financial Statements Alphatec Holdings

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.07 B 1.55 B 1.86 B 1.52 B 1.06 B 1.08 B 364 M 54 M 42.2 M 25.3 M 41.8 M 125 M 215 M 153 M 161 M

Shares

150 M 143 M 121 M 103 M 96.2 M 67 M 52.2 M 35.3 M 12.8 M 8.5 M 8.3 M 8.11 M 8.02 M 7.52 M 7.4 M

Historical Prices

13.8 10.9 15.4 14.7 11 16.1 5.85 1.59 3.19 3.37 2.28 17.4 16.9 19.6 22.6

Net Income

-143 M -162 M -187 M -151 M -143 M -79 M -57 M -29 M -2.29 M -29.9 M -179 M -12.9 M -82.2 M -15.5 M -22.2 M

Revenue

764 M 612 M 482 M 351 M 243 M 145 M 113 M 91.7 M 102 M 120 M 185 M 207 M 205 M 196 M 198 M

Cost of Revenue

232 M 187 M 172 M 118 M 85.4 M 42.4 M 35.8 M 28.5 M 33.5 M 44.1 M 46.4 M 45 M 78.7 M 70.8 M 79.2 M

Gross Profit

532 M 424 M 310 M 233 M 158 M 103 M 77.6 M 63.2 M 62.3 M 76.1 M 122 M 145 M 126 M 126 M 117 M

Operating Income

-82.1 M -136 M -173 M -147 M -128 M -58.9 M -47.3 M -22.4 M -9 M -15.4 M -176 M 1.48 M -73.4 M -9.84 M -24.5 M

Interest Expense

45.9 M 24.9 M 16.6 M 5.5 M 7.11 M 12.4 M 9.86 M -7.14 M -133 K 5.37 M 4 M 3.02 M 3.96 M 6.1 M 3.03 M

EBITDA

-4.64 M -57.8 M -117 M -106 M -101 M -47.9 M -38 M -19.3 M -6.96 M -10.4 M -2.23 M 7.26 M -13 M -4.83 M -11.5 M

Operating Expenses

614 M 560 M 484 M 380 M 286 M 161 M 116 M 83.2 M 70 M 87.5 M 128 M 143 M 144 M 134 M 131 M

General and Administrative Expenses

499 M 450 M 374 M 300 M 229 M 129 M 102 M - 23.2 M 26.3 M 34.9 M 43.4 M 47.9 M 39.9 M 36.4 M

All numbers in USD currency

Quarterly Income Statement Alphatec Holdings

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

150 M 147 M 144 M 143 M 143 M 141 M 139 M 122 M 119 M 110 M 107 M 105 M 103 M 100 M 99.5 M 99.6 M 98.5 M 87.2 M 82.1 M 64.8 M 63.7 M 62.6 M 61.4 M 55.7 M 46.9 M 45 M 43.4 M 42.5 M 34 M 21.2 M 19.9 M 13.9 M 11 M 9 M 9.05 M 8.56 M 8.49 M 8.47 M 8.51 M 8.28 M 99.3 M 99 M 99.9 M 97.4 M 96.9 M 96.8 M 96.7 M 96.4 M 95.9 M 95.8 M 96.7 M 89.5 M 89.2 M 88.9 M 89.4 M 88.8 M 89.4 M 89.4 M

Net Income

-41.1 M -51.9 M - -39.6 M -40.7 M -48.5 M - -42.7 M -51.4 M -43.5 M - -36.8 M -37.1 M -42.6 M - -43 M -38.2 M -22.9 M - -15.7 M -15.8 M -20.7 M - -14.6 M -12.4 M -13 M - -9.36 M -7.08 M -1.92 M - -3.14 M -2.7 M -5.52 M -4.35 M -13.7 M -5.23 M -6.62 M -9.9 M -160 M -3.95 M -4.56 M -273 K -3.04 M -2.9 M -6.67 M -60.4 M -14.5 M -4.66 M -2.65 M -5.36 M -2.47 M -6.37 M -1.26 M -16 M -1.3 M -3.04 M -1.87 M

Revenue

186 M 169 M - 151 M 146 M 138 M - 118 M 117 M 109 M - 89.8 M 84.2 M 70.9 M - 62.9 M 62.2 M 44.1 M - 41.2 M 29.6 M 30.1 M - 29.2 M 27.3 M 24.6 M - 23 M 22 M 21.3 M - 23.1 M 24.4 M 28 M 27.1 M 26.7 M 32.2 M 34.2 M 34.8 M 31.7 M 46.6 M 48.6 M 53.6 M 51 M 53.2 M 49.2 M 53.1 M 50.2 M 51 M 50.4 M 52.7 M 46.8 M 48.2 M 48.5 M 49.5 M 47.6 M 50.9 M 49.7 M

Cost of Revenue

56.4 M 53.2 M - 48 M 43 M 41.1 M - 38.2 M 52.4 M 38.7 M - 30.3 M 28.7 M 21.7 M - 23.3 M 21.2 M 12.3 M - 11.9 M 8.79 M 9.08 M - 9.27 M 8.43 M 7.99 M - 6.8 M 6.49 M 6.4 M - 8.59 M 8.63 M 11.2 M - 10.8 M 11.1 M 9.72 M - 10 M 18.7 M 15.3 M - 14.3 M 16.6 M 15.4 M - 25.5 M 18.5 M 17.3 M - 16.8 M 17.7 M 16.3 M - 17 M 20.6 M 17.4 M

Gross Profit

129 M 116 M - 103 M 103 M 97.4 M - 80 M 64.5 M 70.4 M - 59.5 M 55.5 M 49.2 M - 39.6 M 41.1 M 31.9 M - 29.2 M 20.8 M 21 M - 19.9 M 18.9 M 16.6 M - 16.2 M 15.6 M 14.9 M - 14.5 M 15.7 M 16.8 M 14.6 M 15.9 M 21.2 M 24.5 M 23.6 M 21.7 M 18.3 M 24.5 M 37.7 M 36.3 M 36.1 M 33.3 M 35.3 M 24.2 M 32.1 M 32.7 M 32.1 M 29.6 M 30.2 M 31.8 M 24.9 M 30.2 M 29.9 M 32 M

Operating Income

-13.1 M -44.3 M - -33.7 M -35.3 M -43.3 M - -38.4 M -49.9 M -40.3 M - -35 M -35.7 M -41.2 M - -35.1 M -35.8 M -19 M - -12.9 M -11.2 M -17.8 M - -11.6 M -10.4 M -10.8 M - -7.53 M -6.54 M -667 K - -1.26 M -735 K -3.4 M - -4.55 M -320 K -3.44 M - -165 M -2.83 M 1.14 M - 1.73 M 1.84 M -4.7 M - -13.2 M -2.9 M -1.36 M - -1.97 M -3.75 M -126 K - -2.36 M -3.3 M -2.36 M

Interest Expense

12.3 M 7.84 M - 6.57 M 5.82 M 5.34 M - 4.46 M 3.89 M 3.87 M - 1.28 M 1.44 M 1.46 M - 1.27 M 2.39 M 1.94 M - 2.76 M 3.03 M 2.87 M - 2.92 M - -2.12 M - - -75 K 62 K - -15 K 2 K 5 K - 90 K 3.72 M 3.36 M - 3.11 M 3.04 M 3.37 M - 3.88 M 3.75 M 1.69 M - 1.05 M 927 K 695 K - 774 K 3.58 M 708 K - 725 K 888 K 679 K

EBITDA

1.92 M -24.4 M - -17.2 M -19.6 M -25.5 M - -27.7 M -40.1 M -28.7 M - -27 M -28.2 M -31.9 M - -17.1 M -30.8 M -15.2 M - -5.06 M -6.1 M -15.4 M - -6.24 M -6.98 M -8.98 M - -2.47 M -3.07 M 1.22 M - 4.28 M 3 M -1.53 M - 5.85 M 7.06 M 442 K - -151 M 6.76 M 5.3 M - 15.7 M 11.4 M 149 K - 6.79 M 9.69 M 4.9 M - 15.4 M 7.87 M 5.68 M - 12.6 M 6.68 M 2.64 M

Operating Expenses

142 M 160 M - 136 M 138 M 141 M - 118 M 114 M 111 M - 94.5 M 91.2 M 90.4 M - 74.7 M 76.8 M 50.9 M - 42.1 M 32 M 38.8 M - 31.5 M 29.3 M 27.3 M - 23.7 M 22.1 M 15.6 M - 15.8 M 16.5 M 20.2 M 21.7 M 20.4 M 21.5 M 27.9 M 29.1 M 186 M 23.7 M 24.8 M 34.7 M 34.6 M 34.3 M 38 M 91.3 M 37.4 M 35 M 34.1 M 36.1 M 31.6 M 33.9 M 31.9 M 41.4 M 32.6 M 33.2 M 34.3 M

General and Administrative Expenses

119 M 127 M - 109 M 113 M 114 M - 91.4 M 87.3 M 91.3 M - 76 M 72.7 M 69.5 M - 61.5 M 60.7 M 40.4 M - 35.4 M 26.5 M 27.6 M - 27 M 24.7 M 21.1 M - 7.91 M 7.82 M 6.44 M - 4.4 M 5.35 M 6.22 M - 4.14 M 6.27 M 9 M - 6.54 M 9.24 M 9.14 M - 10.2 M 9.24 M 14.2 M - 11.4 M 11.4 M 11.1 M - 9.76 M 10.1 M 8.82 M - 8.63 M 8.94 M 9.14 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Alphatec Holdings ATEC
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Alphatec Holdings plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Bruker Corporation Bruker Corporation
BRKR
$ 36.74 - $ 5.47 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.38 - $ 266 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 - $ 36.7 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.07 - $ 1.63 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Delcath Systems Delcath Systems
DCTH
$ 9.7 - $ 347 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.45 1.77 % $ 129 M franceFrance
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 81.19 - $ 47.5 B usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.6 - $ 122 M usaUSA
Globus Medical Globus Medical
GMED
$ 88.6 - $ 12 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.9 - $ 1.15 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.31 - $ 717 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 54.14 - $ 1.59 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.0 - $ 16.9 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.63 - $ 2.97 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.94 - $ 374 M usaUSA
LENSAR LENSAR
LNSR
$ 5.89 -2.81 % $ 70.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.28 - $ 111 B usaUSA
Align Technology Align Technology
ALGN
$ 171.87 - $ 12.9 B usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Myomo Myomo
MYO
$ 0.7 - $ 29.3 M usaUSA
AxoGen AxoGen
AXGN
$ 32.64 - $ 1.5 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.77 - $ 466 M curacaoCuracao
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Penumbra Penumbra
PEN
$ 329.87 - $ 12.8 B usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Insulet Corporation Insulet Corporation
PODD
$ 203.5 - $ 14.3 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.53 0.4 % $ 7.02 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.13 -0.24 % $ 874 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 32.63 - $ 23.8 B britainBritain
Stryker Corporation Stryker Corporation
SYK
$ 332.3 - $ 127 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 24.57 - $ 562 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.63 5.47 % $ 29.6 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 104.8 - $ 3.56 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 19.17 - $ 1.3 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA